ranQ
ranQ
ranQ
DirectoryIndustriesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The first Swiss company directory, built to boost AI visibility.

Product
  • Pricing
  • Directory
  • Industries
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint742,806 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical IndustryFreienbachEffRx Pharmaceuticals SA
EffRx Pharmaceuticals SA Logo
Verified· 2 sources

EffRx Pharmaceuticals SA

Summary

About the company

The core activity of EffRx Pharmaceuticals SA is the development, approval and marketing of medicines for rare and niche diseases in Europe and Switzerland. The company focuses particularly on the late-stage development and market entry of therapeutics for patients with rare diseases such as osteoporosis, adrenal insufficiency, congenital adrenal hyperplasia and Niemann-Pick disease. EffRx works closely with partners to develop and bring new medicines to market, offering accelerated decision-making processes and rapid market entry for its customers.

AI-generated
Offering

Products & services

Industry:Pharmaceutical Industry
✓ Offered6
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
Binosto®
Binosto® is a once-weekly effervescent or soluble alendronate formulation for the treatment of osteoporosis; marketed and licensed in several markets.
In-licensing
In-licensing of innovative therapies for Switzerland and Europe, focusing on rare diseases, endocrinology and musculoskeletal indications; includes development, commercialization and market access.
Swiss & European Market Entry
Market entry in Switzerland and Europe for innovative and niche medicines; includes planning, commercialization, launch support and flexible partner solutions.
Rare Diseases – Switzerland
Marketing and provision of medicines for rare diseases in Switzerland, including Alkindi®, Lysodren®, Metopiron® and Miglustat Dipharma®.
Musculoskeletal – Switzerland
Marketing of products for the musculoskeletal area in Switzerland, including Dibase®, Binosto® and Testavan® with professional and patient information.

Knowledge

No knowledge articles yet

Once EffRx Pharmaceuticals SA has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

EffRx Pharmaceuticals SA in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank EffRx Pharmaceuticals SA by reviews, experience and specialisations.

Is this your company?

Claim the company profile of EffRx Pharmaceuticals SA to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Wolleraustrasse 41B
8807 Freienbach

At a glance

Legal form
Corporation
UID
CHE-115.242.363
Founded
2009 · 17 years
Last commercial register change
August 14, 2024
Employees
11 to 20

Similar companies

MA
MediCrops AG
Pfäffikon Sz
MP
Mera Pharma GmbH
Altendorf
OA
Octapharma AG
Lachen Sz
SP
Schwabe Pharma AG
Küssnacht Am Rigi